Lumilis, Jiocel .

HRN: 26-64-35  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/07/2025
CEFUROXIME 750MG (VIAL)
02/07/2025
02/14/2025
INTRAVENOUS
300 Mg IVTT
Every 8 Hours
PCAP-C
Waiting Final Action 
02/08/2025
CEFTRIAXONE 1G (VIAL)
02/08/2025
02/15/2025
IV
800 Mg
Q24
PCAP-C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: